SI3484907T1 - Novi analogi 5'-koncev mrnk s fosfotriazolom, sestavek, ki jih vsebuje, molekula rnk, ki jih vsebuje, njihova uporaba in postopek sintetiziranja molekule rnk, beljakovine ali peptida - Google Patents
Novi analogi 5'-koncev mrnk s fosfotriazolom, sestavek, ki jih vsebuje, molekula rnk, ki jih vsebuje, njihova uporaba in postopek sintetiziranja molekule rnk, beljakovine ali peptidaInfo
- Publication number
- SI3484907T1 SI3484907T1 SI201730371T SI201730371T SI3484907T1 SI 3484907 T1 SI3484907 T1 SI 3484907T1 SI 201730371 T SI201730371 T SI 201730371T SI 201730371 T SI201730371 T SI 201730371T SI 3484907 T1 SI3484907 T1 SI 3484907T1
- Authority
- SI
- Slovenia
- Prior art keywords
- same
- rna molecule
- phosphotriazole
- mrna
- peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL417980A PL417980A1 (pl) | 2016-07-16 | 2016-07-16 | Nowe fosfotriazolowe analogi kapu końca 5' mRNA, kompozycja je zawierająca, cząsteczka RNA je zawierająca, ich zastosowania i sposób syntezy cząsteczki RNA, białka i peptydu |
PCT/IB2017/054221 WO2018015845A1 (en) | 2016-07-16 | 2017-07-12 | Novel phosphotriazole mrna 5'-end cap analogs, composition comprising the same, rna molecule incorporating the same, uses thereof and method of synthesizing rna molecule, protein or peptide |
EP17754482.2A EP3484907B1 (en) | 2016-07-16 | 2017-07-12 | Novel phosphotriazole mrna 5'-end cap analogs, composition comprising the same, rna molecule incorporating the same, uses thereof and method of synthesizing rna molecule, protein or peptide |
Publications (1)
Publication Number | Publication Date |
---|---|
SI3484907T1 true SI3484907T1 (sl) | 2020-12-31 |
Family
ID=59656110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201730371T SI3484907T1 (sl) | 2016-07-16 | 2017-07-12 | Novi analogi 5'-koncev mrnk s fosfotriazolom, sestavek, ki jih vsebuje, molekula rnk, ki jih vsebuje, njihova uporaba in postopek sintetiziranja molekule rnk, beljakovine ali peptida |
Country Status (13)
Country | Link |
---|---|
US (1) | US10696709B2 (sl) |
EP (1) | EP3484907B1 (sl) |
CY (1) | CY1123516T1 (sl) |
DK (1) | DK3484907T3 (sl) |
ES (1) | ES2820242T3 (sl) |
HR (1) | HRP20201274T1 (sl) |
HU (1) | HUE051312T2 (sl) |
LT (1) | LT3484907T (sl) |
PL (2) | PL417980A1 (sl) |
PT (1) | PT3484907T (sl) |
RS (1) | RS60848B1 (sl) |
SI (1) | SI3484907T1 (sl) |
WO (1) | WO2018015845A1 (sl) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023250528A1 (en) * | 2022-06-24 | 2023-12-28 | The Broad Institute, Inc. | Compositions and methods for preparing capped circular rna molecules |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013059475A1 (en) * | 2011-10-18 | 2013-04-25 | Life Technologies Corporation | Alkynyl-derivatized cap analogs, preparation and uses thereof |
-
2016
- 2016-07-16 PL PL417980A patent/PL417980A1/pl unknown
-
2017
- 2017-07-12 RS RS20200968A patent/RS60848B1/sr unknown
- 2017-07-12 HU HUE17754482A patent/HUE051312T2/hu unknown
- 2017-07-12 DK DK17754482.2T patent/DK3484907T3/da active
- 2017-07-12 US US16/318,126 patent/US10696709B2/en active Active
- 2017-07-12 PL PL17754482T patent/PL3484907T3/pl unknown
- 2017-07-12 EP EP17754482.2A patent/EP3484907B1/en active Active
- 2017-07-12 PT PT177544822T patent/PT3484907T/pt unknown
- 2017-07-12 LT LTEP17754482.2T patent/LT3484907T/lt unknown
- 2017-07-12 ES ES17754482T patent/ES2820242T3/es active Active
- 2017-07-12 SI SI201730371T patent/SI3484907T1/sl unknown
- 2017-07-12 WO PCT/IB2017/054221 patent/WO2018015845A1/en unknown
-
2020
- 2020-08-13 HR HRP20201274TT patent/HRP20201274T1/hr unknown
- 2020-08-13 CY CY20201100762T patent/CY1123516T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP3484907A1 (en) | 2019-05-22 |
PT3484907T (pt) | 2020-09-17 |
HRP20201274T1 (hr) | 2020-12-11 |
CY1123516T1 (el) | 2022-03-24 |
WO2018015845A1 (en) | 2018-01-25 |
US20200055891A1 (en) | 2020-02-20 |
RS60848B1 (sr) | 2020-10-30 |
US10696709B2 (en) | 2020-06-30 |
HUE051312T2 (hu) | 2021-03-01 |
DK3484907T3 (da) | 2020-08-17 |
PL3484907T3 (pl) | 2021-02-08 |
LT3484907T (lt) | 2020-09-10 |
ES2820242T3 (es) | 2021-04-20 |
EP3484907B1 (en) | 2020-05-13 |
PL417980A1 (pl) | 2018-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL290633A (en) | 5'-cyclophosphonate modified nucleotides, preparations containing them and their uses | |
SG11202008225PA (en) | Novel rsv rna molecules and compositions for vaccination | |
WO2017024317A3 (en) | Methods to induce targeted protein degradation through bifunctional molecules | |
PH12018501355A1 (en) | Rsv f protein mutants | |
MX2020011257A (es) | Ácidos nucleicos recombinantes que codifican una o más proteínas cosméticas para usos estéticos. | |
WO2017191274A3 (en) | Rna encoding a therapeutic protein | |
HK1243424A1 (zh) | 4'-硫代核苷的新型化合物及其製備方法、藥物組合物和應用 | |
WO2016149455A3 (en) | The rna interactome of polycomb repressive complex 1 (prc1) | |
WO2015006747A3 (en) | Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use | |
WO2016033315A3 (en) | Synthon formation | |
WO2016065349A8 (en) | Short non-coding protein regulatory rnas (sprrnas) and methods of use | |
WO2016205531A3 (en) | Anti-her2 antibodies and methods of use | |
WO2012017324A3 (en) | Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases | |
PL3408276T3 (pl) | 5’-tiofosforanowe analogi końca 5’ mRNA (kapu), mRNA je zawierające, sposób ich otrzymywania i zastosowania | |
EP3560950A4 (en) | NOVEL MUTANT OF ALFA-CONOTOXIN-PEPTIDE-TXID, PHARMACEUTICAL COMPOSITION AND USE OF IT | |
EP4103577A4 (en) | NOVEL 5' END CAP ANALOGS OF MRNA, RNA MOLECULE INCORPORATING THEM, USES THEREOF AND METHODS OF SYNTHESIS OF RNA MOLECULE OR PEPTIDE | |
PH12017500156A1 (en) | Angiopoietin-like 4 antibodies and methods of use | |
WO2017007886A3 (en) | Compositions for inhibiting dux4 gene expression and uses thereof | |
WO2012054907A3 (en) | Novel hemagglutinin 5 (h5) proteins for the treatment and prevention of influenza infections | |
WO2016020882A3 (en) | Angiopoetin-like 4 (angptl4) antibodies and methods of use | |
SG11202106327QA (en) | Oligomeric nucleic acid molecule and application thereof | |
EP3492490A4 (en) | NOVEL AIMP1 PROTEIN FRAGMENT AND HAIR GROWTH PROMOTING COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT | |
WO2016036635A8 (en) | Chromobacterium subtsugae genes | |
MX362058B (es) | Péptido pntx(19) sintético, composición farmacéutica y uso. | |
RS60848B1 (sr) | Novi fosfotriazolni analozi 5'-kapice irnk, kompozicije koje ih sadrže, molekul rnk u koji se ugrađuju, njihova primena i postupak sintetisanja molekula rnk, proteina ili peptida |